Cost effectiveness of sodium zirconium cyclosilicate for the treatment of hyperkalaemia in patients with CKD in Norway and Sweden

Table 1 Model parameters

Characteristic	Mean	Standard error^a
Age (years)	63.33	0.51
Proportion female	0.37	0.02
eGFR (mL/min/1.73 m²)	34.61	0.88
Annual eGFR decline [31]
Annual eGFR decline with RAASi	2.34	0.023
Annual eGFR decline without RAASi	3.52	0.035

eGFR Estimated glomerular filtration rate, RAASi Renin-angiotensin-aldosterone system inhibitors
^a Standard errors used for probabilistic sensitivity analysis; base case uses mean values

ISSN: 1471-2369